1.55
price up icon3.33%   0.05
after-market Dopo l'orario di chiusura: 1.55
loading

Aprea Therapeutics Inc Azioni (APRE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
27.30%
0.1181
0.1625 0.2058 0.3546 0.5616
Operating Expenses
17.47%
3.5059
4.248 3.4319 4.4516 4.4085
Benefits Costs and Expenses
18.02%
3.357
4.0951 3.1006 4.1384 4.0316
Costs And Expenses
17.47%
3.5059
4.248 3.4319 4.4516 4.4085
Operating Income/Loss
17.08%
-3.3878
-4.0856 -3.226 -4.097 -3.8469
Income/Loss From Continuing Operations Before Tax
17.64%
-3.2389
-3.9327 -2.8948 -3.7838 -3.4701
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
17.64%
-3.2389
-3.9327 -2.8948 -3.7838 -3.4701
Net Income/Loss
17.64%
-3.2389
-3.9327 -2.8948 -3.7838 -3.4701
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.49%
6.0833
5.9939 0.1493 5.9398 5.9373
Diluted Average Shares
1.49%
6.0833
5.9939 0.1493 5.9398 5.9373
Basic Earnings Per Share
19.70%
-0.53
-0.66 -0.47 -0.64 -0.58
Diluted Earnings Per Share
19.70%
-0.53
-0.66 -0.57 -0.64 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):